Article
Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications.
British journal of cancer - 1 May 2024
Laguna Juan Carlos, Pastor Belén, Nalda Irene, Hijazo-Pechero Sara, Teixido Cristina, Potrony Miriam, Puig-Butillé Joan Antón, Mezquita Laura
Abstract excerpt
Liquid biopsy, a minimally invasive approach for detecting tumor biomarkers in blood, has emerged as a leading-edge technique in cancer precision medicine. New evidence has shown that liquid biopsies can incidentally detect pathogenic germline variants (PGVs) associated with cancer predisposition, including in patients with a cancer for which genetic testing is not recommended. The ability to detect these...
Topics
- Humans
- Liquid Biopsy
- Germ-Line Mutation
- Neoplasms
- Genetic Predisposition to Disease
- Biomarkers, Tumor
- Incidental Findings
- Prevalence
- Genetic Testing
